Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Triamcinolone and Pirfenidone for Keloid Scars
NCT02823236Phase 3Unknown
- Sponsor
- Centro Dermatológico Dr. Ladislao de la Pascua
- Start
- Oct 2016
- Primary completion
- Dec 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of pirfenidone in keloid, sponsored by Centro Dermatológico Dr. Ladislao de la Pascua. Status: unknown.
02
Drugs
pirfenidone
03
Conditions
keloid
Beyond the preview
Go deeper on NCT02823236.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02823236.